Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 1997Annals of the New York Academy of Sciences

Insights in Vessel Development and Vascular Disorders Using Targeted Inactivation and Transfer of Vascular Endothelial Growth Factor, the Tissue Factor Receptor, and the Plasminogen System

View Full Paper
Ask AI
Bookmark
Share

Authors

Peter Carmeliet
Peter CarmelietVascular MedicineLMLieve MoonsAllen Institute for Brain ScienceMDMieke DewerchinKhalifa University of Science and Technology

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Carmeliet et al. (1997) studied this question.

synapsesocial.com/papers/6a838563102dbb3176604fcahttps://doi.org/10.1111/j.1749-6632.1997.tb52002.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Generation and characterization of urokinase receptor-deficient mice.1996 · 234 citations
  2. 2The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing1991 · 1,986 citations
  3. 3The Role of Plasminogen Activation in Smooth Muscle Cell Migration after Arterial Injury1992 · 90 citations
  4. 4Hypoxia and platelet‐derived growth factor‐BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells1995 · 166 citations
  5. 5Molecular Mechanisms of Developmental and Tumor Angiogenesis1994 · 230 citations